Cargando…
Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer
BACKGROUND: Uncovering the molecular mechanism underlying expansion of hematopoietic stem and progenitor cells is critical to extend current therapeutic applications and to understand how its deregulation relates to leukemia. The characterization of genes commonly relevant to stem/progenitor cell ex...
Autores principales: | Okamoto, Oswaldo Keith, Carvalho, Ana Carolina SR, Marti, Luciana C, Vêncio, Ricardo Z, Moreira-Filho, Carlos A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904434/ https://www.ncbi.nlm.nih.gov/pubmed/17559657 http://dx.doi.org/10.1186/1475-2867-7-11 |
Ejemplares similares
-
Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009) -
Identification of a CD133−CD55− population functions as a fetal common skeletal progenitor
por: Weng, Lihong, et al.
Publicado: (2016) -
Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021) -
Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients
por: Bogoslovsky, Tanya, et al.
Publicado: (2011) -
Pathological features of transplanted tumor established by CD133 positive TJ905 glioblastoma stem-like cells
por: Jin, Feng, et al.
Publicado: (2015)